NSE
Jyothy Labs LimitedJYOTHYLAB
Jyothy Labs Limited is an Indian pharmaceutical company engaged in the manufacturing and distribution of generic drugs, APIs, and healthcare products.
| Key products | Generic drugs, APIs, healthcare products |
|---|---|
| Geography | India (domestic market) |
| Competitors | Dr Reddy's Laboratories, Cipla |
AI-generated overview — verify before relying on it.
Net institutional flow
No institutional deals
Institutional buyers
0 in / 0 out
High-impact filings
0 · tilt Neutral
Next corporate action
Dividend - Rs 3.50 Per Share
ex 2026-06-29
| # | Company | Inst. flow ₹Cr | Deals | Hi-impact | Filing mom. | Buzz | News |
|---|---|---|---|---|---|---|---|
| 1 | ATALREAL | +₹5.2 Cr | 162 | — | — | — | — |
| 2 | QUADFUTURE | +₹0.1 Cr | 148 | — | — | — | — |
| 3 | MOBIKWIK | +₹0.1 Cr | 83 | — | — | — | — |
| 4 | JYOTHYLABThis | — | — | — | — | — | — |
| 5 | MTNL | +₹0 Cr | 2 | — | — | — | — |
| 6 | GATECH | +₹0 Cr | 8 | — | — | — | — |
| 7 | IRMENERGY | −₹2.2 Cr | 328 | — | — | — | — |
Ranked by net institutional flow (buys − sells, ₹Cr). Filing momentum = bullish − bearish filings; Buzz = news+social sentiment. Curate peers in the company admin.
- 2026-06-29ActionDividend - Rs 3.50 Per ShareDividend
- 2026-06-15FilingJyothy Labs Limited has informed the Exchange about Schedule of meetInvestor Call
- 2026-06-15FilingJyothy Labs Limited has informed the Exchange about General UpdatesGeneral
- 2026-06-15FilingJyothy Labs Limited has informed the Exchange regarding Outcome of Board Meeting held on Jun 15, 2026.Board Meeting
- 2026-06-11FilingJyothy Labs Limited has informed the Exchange about Copy of Newspaper PublicationCompliance
Merged from deals, filings, corporate actions and news — newest first. Compact rolls each day up to net flow + counts. Scope with the range above.
Filings that matter
- 2
- 2
- 3
- 1
No bulk/block deals for JYOTHYLAB in this window.
Results & transcripts
News & chatter on JYOTHYLAB
RSS News
0No recent news.
Google News RSS — links open the source.
Investdesk
0No articles yet.
Our coverage.
No Reddit chatter.
r/ posts mentioning the company.
Twitter / X
0No posts.
Posts mentioning the company.